Live Breaking News & Updates on முதுமறதி ஆராய்ச்சி மையம்
Stay updated with breaking news from முதுமறதி ஆராய்ச்சி மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alzheimer's seminar aims to support, educate on inequalities | 92.7 The Van WYVN 927thevan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 927thevan.com Daily Mail and Mail on Sunday newspapers.
Dr. Carl V. Hill COVID-19 has laid bare some undesirable truths: underserved communities are disproportionately impacted by the pandemic. In the field of Alzheimer’s and dementia, statistics point to a similarly troubling trend. According to the Alzheimer’s Association, for instance, African Americans are about twice as likely as whites to have Alzheimer’s or another dementia and Hispanics are 1.5 times more likely to have Alzheimer’s. Additionally, African Americans are more prone to risk factors for vascular disease like diabetes, high blood pressure and high cholesterol which may also be risk factors for Alzheimer’s disease and stroke-related dementia. ....
Bruno Dubois Bruno Dubois is currently Professor of Neurology at the Neurological Institute of the Salpétrière University Hospital at Paris, University Pierre et Marie Curie Paris VI. He is Director of the Behavioural Neurology Department and of the Dementia Research Center at the Hospital. He is also Director of the Research Unit Inserm U-610 of the ICM (Institut du Cerveau et de la Moelle Epinière) of the Hospital. He is coordinator of the National Reference Center on Rare Dementias and of the National Reference Center for young-onset Alzheimer patients. He is President of the Scientific Committee of France-Alzheimer and of IFRAD (International Fund Raising for Alzheimer s disease), consultant for the Human Frontier Program and Expert of the French Agency of Drugs. He is a member of the European Alzheimer Disease Consortium (EADC). He has published on anatomical and biochemical studies on the central cholinergic systems in rodents and humans; on cognitive neuropharmacolo ....
AB Science communicates the results from phase 2B/3 study evaluating masitinib in Alzheimer's disease Paris Stock Exchange:AB globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
AB Science communicates the results from phase 2B/3 study evaluating masitinib in Alzheimer's disease – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.